In the last number of years, the pace of scientific progress has progressed in ways once thought unimaginable. The unique mix of leading universities, hospitals and biopharmaceutical companies puts the city of Boston at the forefront of these discoveries.

As part of an ongoing national dialogue on The New Era of Medicine, PhRMA’s chief medical officer and executive vice president Dr. Bill Chin, sat down with Dr. Joseph Loscalzo, chair of the Department of Medicine, physician-in-chief at Brigham and Women’s Hospital, and Hersey Professor of the Theory and Practice of Medicine at Harvard Medical School, to talk about life-changing innovation–from scientific discovery in a lab all the way to the delivery of therapies that comfort and treat patients.

Dr. Chin explains the way immuno-oncology, one of the most talked about innovative treatments in personalized medicine, targets the body’s immune system to fight cancer. This incredible advancement is being driven in large part by American biopharmaceutical scientists, and is changing the cancer treatment landscape providing patients newfound treatment options.

Innovations aren’t solely focused on cancer as Dr. Loscalzo discusses. Groundbreaking work by researchers is redefining disease, repurposing drugs rationally, and enhancing the placebo effect using modern genomics and network medicine. Each of these developments are driven by scientists’ daily dedication to improving patient lives, which both Drs. Chin and Loscalzo agree researchers cannot succeed without increased collaboration across the health care ecosystem.